Accord Healthcare opens new pharmaceutical facility in Newcastle
Fast growing pharmaceutical companies in the UK and Ireland, Accord Healthcare, has recently opened its new pharmaceutical facility in Fawdon, Newcastle. The move will expand the company’s portfolio and strengthen its supply chain and manufacturing operations.
With the aim to become the largest supplier of genetic medicines across the UK and Ireland, the new facility is situated over 22 acres and will create up to 500 new roles
“Fawdon will play a vital role in strengthening our manufacturing network, supported by our parent company Intas and our other UK sites. After seeing many domestic pharmaceutical manufacturing sites close, with production redirected overseas, this opening marks a vote of confidence in the UK’s attractiveness for high tech pharmaceutical manufacturing,” explained Dr James Burt, Executive Vice President, Europe & MENA, Accord Healthcare.
“We are committed to further strategic investment to support the site’s growth, adding value to the local economy in terms of jobs and exports, as well as furthering patient access to affordable medicines in both the UK and beyond.”
- Ping An Insurance Group is set to list its healthcare division
- Amazon, Berkshire Hathaway and JPMorgan Chase will partner on building new healthcare solutions
- New report highlights the growing trend of healthcare M&A’s
Previously owned by Sanofi before the company relocated to France, the facility will enable the creation of further roles upon the growth of pharmaceutical production, where it will export to over 25 countries across Europe.
Forming part of Accord Healthcare’s five-year strategy, the facility will support the growth of the UK economy, following on from its acquisition of Actavis UK and Ireland in 2017.
“The purchase of Fawdon preserves a legacy of manufacturing in Newcastle that spreads back over 50 years, added Dr Burt.
“We have invested heavily in the site. We have brought in state-of-the-art manufacturing equipment, we have upgraded the quality of the site so the medicines that are produced here are of a higher quality, and we have offered employment prospects back to a lot of people who were on this site previously.
“We are also investing in a laboratory to undertake discovery and development work so we can bring out the next generation of products at this site, and export them all over the world.”
Ultium Cells LLC/Li-Cycle: Sustainable Battery Manufacturing
Ultium Cells LLC - a joint venture between General Motors and LG Energy Solutions - has announced its latest collaboration with Li-Cycle. Joining forces the two have set ambitions to expand recycling in North America, recycling up to 100% of the scrap materials in battery cell manufacturing
What is Ultium Cells LLC?
Announcing their partnership in December 2019, General Motors (GM) and LG Energy Solutions established Ultium Cells LLC with a mission to “ensure excellence of Battery Cell Manufacturing through implementation of best practices from each company to contribute [to the] expansion of a Zero Emission propulsion on a global scale.”
Who is Li-Cycle?
Founded in 2016, Li-Cycle leverages innovative solutions to address emerging and urgent challenges around the world.
As the use of Lithium-ion rechargeable batteries in automotive, industrial energy storage, and consumer electronic applications rises, Li-Cycle believes that “the world needs improved technology and supply chain innovations to better recycle these batteries, while also meeting the rapidly growing demand for critical and scarce battery-grade materials.”
Why are Ultium Cells LLC and Li-Cycle join forces?
By joining forces to expand the recycling of scrap materials in battery cell manufacturing in North America, the new recycling process will allow Ultium Cells LLC to recycle cobalt, nickel, lithium, graphite, copper, manganese and aluminum.
“95% of these materials can be used in the production of new batteries or for adjacent industries,” says GM, who explains that the new hydrometallurgical process emits 30% less greenhouse gases (GHGs) than traditional processes, minimising the environmental impact. Use of this process will begin later in the year (2021).
"Our combined efforts with Ultium Cells will be instrumental in redirecting battery manufacturing scrap from landfills and returning a substantial amount of valuable battery-grade materials back into the battery supply chain. This partnership is a critical step forward in advancing our proven lithium-ion resource recovery technology as a more sustainable alternative to mining, " said Ajay Kochhar, President, CEO and co-founder of Li-Cycle.
"GM's zero-waste initiative aims to divert more than 90% of its manufacturing waste from landfills and incineration globally by 2025. Now, we're going to work closely with Ultium Cells and Li-Cycle to help the industry get even better use out of the materials,” added Ken Morris, Vice President of Electric and Autonomous Vehicles, GM.
Since 2013, GM has recycled or reused 100% of the battery packs it has received from customers, with most current GM EVs repaired with refurbished packs.
"We strive to make more with less waste and energy expended. This is a crucial step in improving the sustainability of our components and manufacturing processes,” concluded Thomas Gallagher, Chief Operating Officer, Ultium Cells LLC.